Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet

Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet

Product Details:

  • Grade Pharmaceutical Grade
  • Dosage Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
  • Appearance Film-coated tablet
  • Storage Store below 30°C in a dry place protected from light
  • Usage Used in combination as part of antiretroviral therapy for HIV infections
  • CAS No 1051375-16-6 1434910-92-0 379270-37-8
  • Origin of Medicine Synthetic
  • Click to view more
X

Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet Product Specifications

  • Dolutegravir sodium Emtricitabine Tenofovir Alafenamide
  • Treatment of HIV-1 infection
  • Tablet
  • 2 years from date of manufacture
  • Greater than 99% purity
  • Antiretroviral
  • Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
  • Pharmaceutical Grade
  • Store below 30°C in a dry place protected from light
  • Film-coated tablet
  • 1051375-16-6 1434910-92-0 379270-37-8
  • Used in combination as part of antiretroviral therapy for HIV infections
  • 30 tablets per box
  • Synthetic
  • C20H19F2N3O5 C8H10FN3O3S C21H29N6O5P

Product Description



Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet is a pharmaceutical-grade medication used in combination as part of antiretroviral therapy for HIV infections. Each film-coated tablet contains Dolutegravir 50mg, Emtricitabine 200mg, and Tenofovir Alafenamide 25mg. This medication is manufactured by Emcure under the brand name Spegra. It is a prescription medication for the treatment of HIV-1 infection. With a purity greater than 99%, this tablet has an expiration date of 2 years from the date of manufacture. It should be stored below 30C in a dry place protected from light.

Manufacturer Emcure
Brand Spegra
Prescription/Non prescription Prescription
Treatment Anti HIV
Composition Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg)
Packaging Size 30 Tablets Bottle


FAQs of Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet:


Q: What is the composition of Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet?

A: The tablet contains Dolutegravir 50mg, Emtricitabine 200mg, and Tenofovir Alafenamide 25mg.

Q: How should Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet be stored?

A: It should be stored below 30C in a dry place protected from light.

Q: What is the manufacturer of this tablet?

A: Emcure is the manufacturer of Dolutegravir Emtricitabine And Tenofovir Alafenamide Tablet.

Q: What is the shelf life of this medication?

A: The expiration date of this tablet is 2 years from the date of manufacture.

Q: For what indication is this medication used?

A: It is used for the treatment of HIV-1 infection.

Other Products in 'HIV Medicine' category



Get in touch with us
RFQ Request For Quotation
Get Quotes For Your Buying Requirement. Tell Suppliers What You Need.
I agree to abide by all the Terms and Conditions of tradeindia.com